Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan - Wikidata - wikimedia - TriplyDB

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

http://www.wikidata.org/entity/Q57167691

about

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

http://www.wikidata.org/entity/Q57167691

description

article publié dans la revue scientifique PLoS ONE

@fr

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in PLoS ONE

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

@en

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

@nl

type

label

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

@en

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

@nl

prefLabel

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

@en

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

@nl

P1433

Q57167691-B73A7E8E-E08B-420D-91B7-35C838B59B22

P1476

Q57167691-D4E7373A-5C0F-4912-BE46-F943BF5F5862

P2093

Q57167691-0FDECE87-DE8A-4056-A69C-B7E3838EAF38

Q57167691-132DC880-23D0-434D-A197-CA9163372C4B

Q57167691-8315A2BA-BD23-4562-8A45-974750B51528

P2860

Q57167691-01304FBE-A9FD-4485-A472-E98981C41E83

Q57167691-017B83E3-B265-4EB8-B44A-510BAE3B0536

Q57167691-130C0950-FE28-48C7-9BB7-AC532D40D5F4

Q57167691-2636B45F-2348-4D58-A918-7C243D54C639

Q57167691-5A10B70F-41AA-43FA-B463-335EE41A7CAA

Q57167691-89D9A9F1-1116-4A8B-9F21-F3A7714C3292

Q57167691-9259AF75-A604-4843-B336-BC102A73D497

Q57167691-A5D41F1E-5ADB-49F9-96FE-9151CB1332F7

Q57167691-AC3B66B6-B0DF-4978-98F1-FFCEFCA4DC77

Q57167691-AD95DD28-36EC-4B81-974E-DC4C2E85817A

P304

Q57167691-22A2424D-26F7-4F57-9B58-DBD982C234BC

P31

Q57167691-FB7521F4-955B-4969-BAD5-26E19D139B94

P356

Q57167691-FACD76BE-C4FE-411E-9FF3-60A863A9E069

P407

Q57167691-0DE0780A-A49C-4B40-98CA-9B6EF23DE5CB

P433

Q57167691-561CB21B-6F03-4D13-8773-DAAC18D969F6

P478

Q57167691-38AFB310-FD33-40C0-89FF-4FD583BE45A7

P50

Q57167691-C38C33FD-8A8C-4710-8C37-243F39D457FF

P577

Q57167691-A89E7358-31E4-4FB2-AC4F-9D48FE873200

P698

Q57167691-00398849-A4B4-4A8E-81D7-83EE4361CAC1

P932

Q57167691-2704AD96-71F9-4FBF-ABDB-C2DE292F902F

P356

JOURNAL.PONE.0202725

P1433

P1476

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

@en

P2093

Jia-Yu Lin

http://www.w3.org/2001/XMLSchema#string

May-Ying Hsu

http://www.w3.org/2001/XMLSchema#string

Peng-Chan Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Nivolumab in previously untreated melanoma without BRAF mutation

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.

P304

e0202725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0202725

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30142174

http://www.w3.org/2001/XMLSchema#string

P932

6108484

http://www.w3.org/2001/XMLSchema#string